Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids.

PubWeight™: 2.42‹?› | Rank: Top 2%

🔗 View Article (PMC 2729246)

Published in Surg Gynecol Obstet on June 01, 1982

Authors

T E Starzl, T R Hakala, J T Rosenthal, S Iwatsuki, B W Shaw

Articles citing this

Evolution of liver transplantation. Hepatology (1982) 19.54

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet (1995) 2.04

Current status of hepatic transplantation. Semin Liver Dis (1983) 1.75

Factors in the Development of Liver Transplantation. Transplant Proc (1985) 1.74

The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71

Immunosuppression and other nonsurgical factors in the improved results of liver transplantation. Semin Liver Dis (1985) 1.62

Liver and kidney transplantation in children receiving cyclosporin A and steroids. J Pediatr (1982) 1.54

Cadaveric renal transplantation under cyclosporine-steroid therapy. Surg Gynecol Obstet (1983) 1.29

Liver transplantation in the ciclosporin era. Prog Allergy (1986) 1.14

Nephrotoxicity of cyclosporine in liver transplantation. Transplant Proc (1985) 1.04

Steps in immunosuppression for renal transplantation. Kidney Int Suppl (1983) 0.93

Experience with cyclosporine and steroids in clinical renal transplantation. Ann Surg (1984) 0.92

Cadaveric Renal Transplantation With Cyclosporin-A and Steroids. Transplant Proc (1983) 0.88

Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. Nephron (1987) 0.85

Cyclosporine immunosuppression and delayed graft function in 455 cadaveric renal transplants. Transplant Proc (1987) 0.85

Second cadaver kidney transplants: improved graft survival in secondary kidney transplants using cyclosporin A. J Urol (1984) 0.80

Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants. Am J Kidney Dis (1985) 0.78

The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl (1995) 0.76

Long-term results of cyclosporine-steroid therapy in 131 non-matched cadaveric renal transplants. Clin Transplant (1987) 0.75

Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. Am J Kidney Dis (1998) 0.75

Cyclosporine. Kidney transplantation. Transplant Proc (1983) 0.75

Histiocytic Lymphoma in Renal Transplant Patients Receiving Cyclosporine. Transplant Proc (1983) 0.75

Cadaveric Renal Transplantation in Diabetics in the 1980's: with Special Reference to Cyclosporine. Diabet Nephrop (1983) 0.75

Articles cited by this

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29

Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions (1976) 9.68

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet (1980) 4.21

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92

Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67

Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49

Immunological and pharmacological monitoring in the clinical use of cyclosporin A. Lancet (1981) 1.77

Sixteen months experience with cyclosporin-A in human kidney transplantation. Transplant Proc (1981) 1.35

Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts. Transplantation (1982) 1.28

100 second renal allografts from a single transplantation institution. Transplantation (1979) 1.14

Cyclosporin A for the oliguric renal transplant patient. Lancet (1981) 1.03

99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A. Radiology (1982) 0.95

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Changes in blood coagulation. Arch Surg (1966) 3.22

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15